RCE 7.27% 59.0¢ recce pharmaceuticals ltd

Ann: Appendix 4E and Unaudited Preliminary Report, page-4

  1. 64 Posts.
    lightbulb Created with Sketch. 10
    How can Recce justify such significant increases in remuneration for its executives?

    Total remuneration up 73%

    Total employee benefits expense up 78%

    James and Michelle's base remuneration up over 60% each.

    Travel costs nearly $1 million yet Recce has focussed its trials etc in Australia.

    Current operations are now being funded via debt from Radium Capital.

    At 30 June 2023 the company had significant negative net assets, what a disaster.

    Financially, management appears to be out of their depth.

    Surely it is time for an experienced CEO to be appointed!!!
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
59.0¢
Change
0.040(7.27%)
Mkt cap ! $120.3M
Open High Low Value Volume
55.5¢ 59.0¢ 55.5¢ $124.6K 221.4K

Buyers (Bids)

No. Vol. Price($)
1 34834 58.5¢
 

Sellers (Offers)

Price($) Vol. No.
59.0¢ 20276 2
View Market Depth
Last trade - 15.57pm 18/06/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.